NCT02367417

Brief Summary

The objective of this study is to collect outcome information on patients requiring Total Knee Replacement (TKR) in primary or revision cases and therefore receiving the LINK® Endo-Model® SL® under routine conditions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2017

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 20, 2015

Completed
2.5 years until next milestone

Study Start

First participant enrolled

August 14, 2017

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 12, 2023

Status Verified

January 1, 2023

Enrollment Period

7.1 years

First QC Date

February 12, 2015

Last Update Submit

January 11, 2023

Conditions

Keywords

RevisionKnee JointPMCFEndo-Modell SL

Outcome Measures

Primary Outcomes (1)

  • KOOS

    Knee Injury and Osteoarthritis Outcome Score

    1 yr, 3 yrs and 5 yrs

Secondary Outcomes (4)

  • Complications

    At each Follow-up, up to 5 years

  • Rate of subsequent surgical interventions

    At each Follow-up, up to 5 years

  • KSS

    at 3 months, 1 year and 5 years

  • Prosthetic Survival Rate

    up to 5 years

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All subjects enrolled in the PMCF in compliance with the inclusion/exclusion criteria who signed the Informed Consent Form and received the Endo-Model SL® prosthesis, will be included in the primary and secondary endpoint analysis.

You may qualify if:

  • Implantation of the LINK® Endo-Model® SL®.
  • Between 18 and 78 years of age.
  • Patient has signed the Informed Consent. The indications and contraindications for the implantation of the LINK® Endo-Model® SL® listed in the product catalogue and chapter 2.5 and 2.6 \[of the protocol\] are applicable and have to be considered / fulfilled

You may not qualify if:

  • Body Mass Index (BMI) \> 40 kg/m2
  • Poor general state of health with a foreseeable life expectancy of less than 5 years
  • Knee replacement on the contralateral side within the last year and with a KSS fuctional score \< 70 points
  • Comorbidities and known medical circumstances which forseeable affect the clinical functional results after implantation (e.g. neurological or musculoskeletal impairments)
  • Revision in floride septic environment
  • Female patient who is pregnant
  • Prisoner
  • Patient who, as judged by the surgeon, is mentally incompetent or is unlikely to be compliant with the prescribed postoperative routine and follow-up evaluation schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Universitätsklinikum Carl Gustav Carus

Dresden, Saxony, 01307, Germany

Location

Medizinische Fakultät Orthopädische Universitätsklinik (KORT)

Magdeburg, Saxony-Anhalt, 39120, Germany

Location

Evangelisches Waldkrankenhaus Spandau

Berlin, 13589, Germany

Location

MeSH Terms

Conditions

OsteonecrosisArthritisOsteoarthritis

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsJoint DiseasesRheumatic Diseases

Study Officials

  • Christoph Lohmann, Prof. Dr.

    Medizinische Fakultät Orthopädische Universitätsklinik (KORT), Magdeburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2015

First Posted

February 20, 2015

Study Start

August 14, 2017

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

January 12, 2023

Record last verified: 2023-01

Locations